Literature DB >> 12920028

Regulation of tissue factor cytoplasmic domain phosphorylation by palmitoylation.

Andrea Dorfleutner1, Wolfram Ruf.   

Abstract

The tissue factor (TF)-initiated coagulation pathway plays important roles in hemostasis, inflammation, metastasis, and angiogenesis. Phosphorylation of the TF cytoplasmic domain is functionally relevant in metastasis. How TF cytoplasmic domain phosphorylation downstream of protein kinase C (PKC) activation is regulated in primary vascular cells remains poorly understood. Here, phosphorylation of Ser258, rather than the PKC consensus site Ser253, is identified as the major conformational switch required for recognition by a phosphorylation-specific antibody. With this novel reagent, we demonstrate that the TF cytoplasmic domain is primarily unphosphorylated in confluent endothelial cells. TF cytoplasmic domain phosphorylation can occur in the absence of the autologous TF transmembrane and extracellular domains but requires maturation of TF in the Golgi compartment and cell surface expression. Site-directed mutagenesis and 2-bromopalmitate treatment provide evidence that palmitoylation of the cytoplasmic Cys245 is a negative regulatory mechanism of Ser258 phosphorylation. Profiling with PKC-selective inhibitors identifies PKCalpha as important for TF cytoplasmic domain phosphorylation. Mutagenesis of protein kinase consensus sites are consistent with a model in which PKC-dependent phosphorylation of Ser253 enhances subsequent Ser258 phosphorylation by a Pro-directed kinase. Thus, cell surface location-dependent phosphorylation of the TF cytoplasmic domain is regulated at multiple levels.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12920028     DOI: 10.1182/blood-2003-04-1149

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  33 in total

1.  Factor VII deficiency impairs cutaneous wound healing in mice.

Authors:  Zhi Xu; Haifeng Xu; Victoria A Ploplis; Francis J Castellino
Journal:  Mol Med       Date:  2010-02-11       Impact factor: 6.354

2.  Tissue factor and PAR1 promote microbiota-induced intestinal vascular remodelling.

Authors:  Christoph Reinhardt; Mattias Bergentall; Thomas U Greiner; Florence Schaffner; Gunnel Ostergren-Lundén; Lars C Petersen; Wolfram Ruf; Fredrik Bäckhed
Journal:  Nature       Date:  2012-03-11       Impact factor: 49.962

Review 3.  Proteases display biased agonism at protease-activated receptors: location matters!

Authors:  Angela Russo; Unice J K Soh; JoAnn Trejo
Journal:  Mol Interv       Date:  2009-04

4.  Proteomic analysis of palmitoylated platelet proteins.

Authors:  Louisa Dowal; Wei Yang; Michael R Freeman; Hanno Steen; Robert Flaumenhaft
Journal:  Blood       Date:  2011-08-02       Impact factor: 22.113

5.  Protein Lipidation: Occurrence, Mechanisms, Biological Functions, and Enabling Technologies.

Authors:  Hong Jiang; Xiaoyu Zhang; Xiao Chen; Pornpun Aramsangtienchai; Zhen Tong; Hening Lin
Journal:  Chem Rev       Date:  2018-01-02       Impact factor: 60.622

Review 6.  Tissue factor: newer concepts in thrombosis and its role beyond thrombosis and hemostasis.

Authors:  Giovanni Cimmino; Plinio Cirillo
Journal:  Cardiovasc Diagn Ther       Date:  2018-10

7.  Carbohydrates and activity of natural and recombinant tissue factor.

Authors:  Jolanta Krudysz-Amblo; Mark E Jennings; Kenneth G Mann; Saulius Butenas
Journal:  J Biol Chem       Date:  2009-12-02       Impact factor: 5.157

8.  Cross-talk of integrin alpha3beta1 and tissue factor in cell migration.

Authors:  Andrea Dorfleutner; Edith Hintermann; Takehiko Tarui; Yoshikazu Takada; Wolfram Ruf
Journal:  Mol Biol Cell       Date:  2004-07-14       Impact factor: 4.138

Review 9.  Targeting clotting proteins in cancer therapy - progress and challenges.

Authors:  Wolfram Ruf; Andrea S Rothmeier; Claudine Graf
Journal:  Thromb Res       Date:  2016-04       Impact factor: 3.944

Review 10.  Regulation of tissue factor coagulant activity on cell surfaces.

Authors:  L V M Rao; U R Pendurthi
Journal:  J Thromb Haemost       Date:  2012-11       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.